Company Profile
Updated: 13-NOV-09AstraZeneca Bulgaria
International subsidiary
Bul Dragan Tzankov 36, Sofia, 1040, Bulgaria
()359 02 971 2533, 359 02 971 1124 fax, http://www.astrazeneca.bg
Primary SIC: Drugs, Proprietaries And Sundries, Primary NAICS: Drugs and Druggists' Sundries Merchant Wholesalers
Description: Wholesale: Sale of pharmaceutical products
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Research and Markets: Czech Republic Pharmaceuticals and Healthcare Report - the Comprehensive Updated Q4 2009 Edition.(Report)
Business Wire; 11/3/2009; 1232 words; ...Czech Republic, Slovakia, Romania, Hungary, Estonia and Bulgaria, should generate annual turnover of approximately EUR17mn...Demographic Data * BMI Methodology Companies Mentioned: * AstraZeneca * Bristol-Myers Squibb * Sanofi-Aventis * Walmark * Zentiva...
Czech Republic Pharmaceuticals and Healthcare Report - The Comprehensive Updated Q4 2009 Edition.
M2 Presswire; 11/3/2009; 1053 words; ...Czech Republic, Slovakia, Romania, Hungary, Estonia and Bulgaria, should generate annual turnover of approximately EUR17mn...Demographic Data - BMI Methodology Companies Mentioned: - AstraZeneca - Bristol-Myers Squibb - Sanofi-Aventis - Walmark - Zentiva...
The World Pharmaceutical Markets Fact Book 2009: Facts, Figures, Forecasts and Statistics on Pharmaceutical Markets and Companies Around the World.
M2 Presswire; 8/19/2009; 830 words; ...financial performance figures on leading companies from Abbott and AstraZeneca to UCB and Watson. Answer questions such as: - Which country...demographic development is affecting the market in Poland and Bulgaria? - What will the value of the Russian pharmaceutical market...
Research and Markets: The World Pharmaceutical Markets Fact Book 2009 - Facts, Figures, Forecasts and Statistics on Pharmaceutical Markets and Companies around the World.
Business Wire; 8/19/2009; 731 words; ...financial performance figures on leading companies from Abbott and AstraZeneca to UCB and Watson. Answer questions such as: * Which country...demographic development is affecting the market in Poland and Bulgaria? * What will the value of the Russian pharmaceutical market...
Alcon Reports Solid Financial Results for Second Quarter.
Angiogenesis Weekly; 8/7/2009; 2061 words; ...collaborative research agreement with AstraZeneca for the exclusive ophthalmic discovery...potential development rights to AstraZeneca's compound library. The agreement...National licenses have been issued by Bulgaria, Iceland and Romania and the...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning